QuantalX Neuroscience

QuantalX Neuroscience has developed the Delphi-MD platform—a non-invasive diagnostic medical device using focused transcranial magnetic stimulation to objectively assess brain network function. The system enables early detection of neurological disorders such as normal pressure hydrocephalus, stroke risk, and various dementias. It has received multiple FDA breakthrough designations based on positive clinical data showing improved diagnostic accuracy over standard-of-care methods. The company has also secured a dedicated US reimbursement code and CE MDR approval in Europe. Ongoing collaborations aim to expand its clinical utility across additional neurodegenerative diseases.